1. At a Glance
An agrochemical smallcap with a ₹300+ share price and a P/E ratio that could launch a rocket (282). While its peers rake in crores in profits, Bhagiradha delivers a shocker: negative PAT in Q4 FY25. But behind the fog is a Rs. 368 crore bet on its newly activated subsidiary and patented processes. Is this just the build-up phase before the boom?
2. Introduction with Hook
Imagine spending ₹300 on a bag of fertilizer, opening it, and finding… just hope. That’s Bhagiradha Chemicals right now. Its P/E ratio screams “valued like a unicorn,” while its last quarter says “Hi, I lost ₹0.88 crore.” But wait, there’s more. A brand-new plant is up, a ₹368 crore loan was just turned into equity for its subsidiary, and patents are getting inked.
Key Stat 1: Q4 FY25 Net Loss: ₹0.88 crore
Key Stat 2: Debtor Days: A whopping 144 (vs 111 a year ago)
3. Business Model (WTF Do They Even Do?)
Bhagiradha is into the dirty (read: profitable) work of agrochemical manufacturing. Their catalog features:
- Insecticides: Chlorpyrifos, Diafenthiuron, Fipronil
- Fungicides: Azoxystrobin
- Herbicides: Imazethapyr, Clodinafop-propargyl
- Intermediates: 2,6-Dichloroaniline, R-HPPA
Their edge? Complex chemistry + IP-driven approach (hello patents!) + upstream
